Platinum Investment Management LTD Adc Therapeutics Sa Transaction History
Platinum Investment Management LTD
- $1.4 Billion
- Q2 2025
A detailed history of Platinum Investment Management LTD transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,387,265 shares of ADCT stock, worth $4.08 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,387,265
Previous 2,038,087
31.93%
Holding current value
$4.08 Million
Previous $2.87 Million
29.38%
% of portfolio
0.27%
Previous 0.18%
Shares
5 transactions
Others Institutions Holding ADCT
# of Institutions
91Shares Held
67.9MCall Options Held
68.2KPut Options Held
75.8K-
Redmile Group, LLC San Francisco, CA15.7MShares$46.1 Million5.11% of portfolio
-
Prosight Management, LP Dallas, TX10.5MShares$30.8 Million7.6% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct7.76MShares$22.8 Million0.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.91MShares$17.4 Million0.57% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$10.5 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $228M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...